drugset
drugset / Trial / NCT03467971

A Study to Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants

NCT03467971 ↗

Phase 1 Completed 21 enrolled Merck KGaA, Darmstadt, Germany
RandomizedCrossoverOpen-labelOther

Summary

This study will assess the food effect on bioavailability of Metformin/Gliclazide fixed dose combination tablet in fed and fasted state.

Timeline

Start
2018-03-06
Primary completion
2018-04-22
Completion
2018-04-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Gliclazide Small molecule 30 mg Oral
Subject Metformin Small molecule 1000 mg Oral

Indications

No indication recorded.